|
DCK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.319560E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.518000E-01 |
| Normal-vs-Stage2 |
8.283500E-03 |
| Normal-vs-Stage3 |
1.082550E-01 |
| Normal-vs-Stage4 |
2.008800E-01 |
| Stage1-vs-Stage2 |
1.122070E-02 |
| Stage1-vs-Stage3 |
2.964000E-01 |
| Stage1-vs-Stage4 |
6.171200E-01 |
| Stage2-vs-Stage3 |
1.043200E-01 |
| Stage2-vs-Stage4 |
1.018960E-01 |
| Stage3-vs-Stage4 |
8.004800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.982390E-01 |
| Normal-vs-AfricanAmerican |
3.087600E-01 |
| Normal-vs-Asian |
1.052770E-01 |
| Caucasian-vs-AfricanAmerican |
9.921400E-01 |
| Caucasian-vs-Asian |
4.751800E-01 |
| AfricanAmerican-vs-Asian |
5.842600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.062970E-01 |
| Normal-vs-Female |
1.559390E-01 |
| Male-vs-Female |
5.532600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.557400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.115500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.350170E-01 |
| Normal-vs-Age(81-100Yrs) |
5.959200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.262400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.733160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.500800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.573400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.174400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.473800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.908600E-01 |
| Classical-VS-Follicular |
3.440500E-02 |
| Classical-VS-Other |
6.376800E-01 |
| Classical-VS-Normal |
2.556000E-01 |
| Tall-VS-Follicular |
4.600200E-02 |
| Tall-VS-Other |
3.977600E-01 |
| Tall-VS-Normal |
7.350800E-01 |
| Follicular-VS-Other |
8.214400E-01 |
| Follicular-VS-Normal |
3.581700E-02 |
| Other-VS-Normal |
4.571800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.549700E-02 |
| Normal-vs-N1 |
3.988200E-02 |
| N0-vs-N1 |
5.637600E-01 |
|
|
